Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Researchers develop new precision medicine technology for cancer immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionized areas of cancer care.

28 Feb 2022

ESMO announces a new series of resources to guide physicians in oncological practice

ESMO, the leading professional organization for medical oncology, announces a new series of resources designed to guide physicians in areas of oncological practice not covered by guidelines, where current evidence is insufficient to evenly inform clinical decision-making.

28 Feb 2022

Study finds the optimal duration of treatments for patients with high-risk prostate cancer

Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy.

25 Feb 2022

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

Novocure announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption activates the immune system and triggers an anti-tumor cell response that may be effectively used together with existing immunotherapy approaches in the treatment of solid tumors, with limited systemic toxicity.

25 Feb 2022

ESC Acute CardioVascular Care 2022 to focus on management of cardiac emergencies

Cutting edge management of urgent heart problems will be revealed during ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

25 Feb 2022

DNA biomarker test helps predict recurrence of HPV-driven oropharyngeal cancer after treatment

A large, multi-institutional study demonstrates that a blood test to detect circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment.

25 Feb 2022

AI model could be a low-cost, non-invasive option for thyroid cancer screening and staging

A new study finds that an artificial intelligence (AI) model incorporating multiple methods of machine learning accurately detects thyroid cancer and predicts pathological and genomic outcomes through analysis of routine ultrasound images.

24 Feb 2022

Phase I clinical trial evaluates AI-discovered first anti-fibrotic small molecule inhibitor

Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that it has dosed multiple healthy volunteers in Phase I clinical trial evaluating ISM001-055, the first anti-fibrotic small molecule inhibitor generated by Insilico's AI-powered drug discovery platform for idiopathic pulmonary fibrosis (IPF).

24 Feb 2022

Scientists uncover new role of chromatin-modulatory enzyme during cancer development

Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.

24 Feb 2022

New analysis on intersectionality in cancer care

Intersectionality posits that social categorizations and personal identities are interconnected in a way that creates a unique nuanced lived experience for individuals rather than an additive experience.

24 Feb 2022

New combination treatment strategy for managing metastatic hormone-sensitive prostate cancer

A new drug, administered in combination with standard androgen-deprivation therapy and docetaxel chemotherapy, increased survival in patients with metastatic hormone-sensitive prostate cancer, according to a trial published in The New England Journal of Medicine.

23 Feb 2022

Why is it Important to Democratize Proteomics Data?

In this interview, we speak to Steve Kosteski from IsoPlexis about the importance of single-cell proteomics within the life sciences sector.

From Society for Laboratory Automation and Screening (SLAS) 23 Feb 2022

ecancer's pioneering initiative aims to improve the care of cancer patients in poorest countries

ecancer, the global cancer education charity, is launching a pioneering initiative, with funding from Bristol Myers Squibb (BMS), which aims to improve the care of cancer patients in the poorest countries across the world.

21 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

Combination of three drugs extends the survival of patients with metastatic, hormone-sensitive prostate cancer

Results from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy prolongs the survival of men with metastatic, hormone-sensitive prostate cancer, a disease that is fatal in most cases.

18 Feb 2022

Exposure to endocrine disrupting mixtures during pregnancy impacts children's brain development

By linking human population studies with experiments in cell and animal models, researchers have provided evidence that complex mixtures of endocrine disrupting chemicals impact children's brain development and language acquisition.

17 Feb 2022

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published Feb. 17, 2022, in JAMA Oncology.

17 Feb 2022

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

Treating a tumor in the breast when distant metastases have already occurred does not improve outcomes in women with stage IV breast cancer, according to a new study published in the Journal of Clinical Oncology.

17 Feb 2022

New NYU Langone Ambulatory Care Center East 53rd Street offers gynecologic, obstetric, and wellness care

As part of its commitment to enhance access to high-quality care, NYU Langone Health has begun the phased opening of NYU Langone Ambulatory Care Center East 53rd Street, at 159 East 53rd Street, offering comprehensive gynecologic, obstetric, and wellness care.

17 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Oncology News and Research

Further Reading

Researchers develop new precision medicine technology for cancer immunotherapy

ESMO announces a new series of resources to guide physicians in oncological practice

Study finds the optimal duration of treatments for patients with high-risk prostate cancer

Treatment with Tumor Treating Fields triggers downstream anti-tumor cell response, study finds

ESC Acute CardioVascular Care 2022 to focus on management of cardiac emergencies

DNA biomarker test helps predict recurrence of HPV-driven oropharyngeal cancer after treatment

AI model could be a low-cost, non-invasive option for thyroid cancer screening and staging

Phase I clinical trial evaluates AI-discovered first anti-fibrotic small molecule inhibitor

Scientists uncover new role of chromatin-modulatory enzyme during cancer development

New analysis on intersectionality in cancer care

New combination treatment strategy for managing metastatic hormone-sensitive prostate cancer

Why is it Important to Democratize Proteomics Data?

ecancer's pioneering initiative aims to improve the care of cancer patients in poorest countries

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Combination of three drugs extends the survival of patients with metastatic, hormone-sensitive prostate cancer

Exposure to endocrine disrupting mixtures during pregnancy impacts children's brain development

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Locoregional treatment does not improve outcomes in women with stage IV breast cancer

New NYU Langone Ambulatory Care Center East 53rd Street offers gynecologic, obstetric, and wellness care

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Cancer Research - Second Edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News